03 July 2024 : Clinical Research
Cystatin SN (CST1) Is a Poor Independent Prognostic Biomarker for Gastrointestinal Diffuse Large B-Cell Lymphoma
Jie Wang1ABCDEFG*, Ming Yang2CD, Sheng Chen2CEF, Hongbo Zhu1AB, Zhirong Zhang1CDDOI: 10.12659/MSM.943551
Med Sci Monit 2024; 30:e943551
Figure 1 The expression of CST1 in GI-DLBCL(A) The expressions of CST1 in 84 cases of GI-DLBCL were detected with immunohistochemistry (IHC). The patients were classified into subgroups with low and high expression of CST1. The IHC scores of representative images of left and right panel is 0 and 9 respectively. (B) The expressions of CST1 in 7 cases of GI-DLBCL tissues and adjacent GI tissues were detected with RT-qPCR. The statistical significance was analyzed by compared t test. Graphpad Prism 5 and Adobe Illustrator CS5 were used to generate this figure.